Flaws in a Tumor’s Genetic Mending Kit Drive Treatment Response to Immunotherapy – Newswise (press release)
|
Flaws in a Tumor's Genetic Mending Kit Drive Treatment Response to Immunotherapy
Newswise (press release) “Our study results may lead to a new standard-of-care that includes mismatch repair deficiency testing to help identify a wider group of patients who have failed other therapies but may benefit from immunotherapy drugs.” says Dung Le, M.D., oncologist … |
